Addressing the challenge of platinum-resistant ovarian cancer: the role of mirvetuximab soravtansine

被引：0
|
作者：
Shaukat, Ayesha [1 ]
Shakeel, Laiba [1 ]
Khan, Afsheen [1 ]
Irfan, Hamza [2 ]
Akilimali, Aymar [3 ]
机构：
[1] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan
[2] Shaikh Khalifa Bin Zayed Al Nahyan Med & Dent Coll, Dept Internal Med, Lahore, Pakistan
[3] Med Res Circle, Dept Res, Goma, DEM REP CONGO
来源：
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词：
EXPRESSION; CISPLATIN; WOMEN;
D O I：
10.1097/MS9.0000000000002759
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [31] Gemcitabine and anthracyclines in platinum-resistant ovarian cancer
    Galligioni, E.
    Arcuri, C.
    Sorio, R.
    Griso, C.
    ANNALS OF ONCOLOGY, 2006, 17 : V195 - V198
  • [32] ECONOMIC BURDEN IN PLATINUM-RESISTANT OVARIAN CANCER
    Indukuri, Nikhila
    Musat, Mihaela
    Chavez, Gordon
    Proescholdt, Christina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A142 - A142
  • [33] The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community
    Petrillo, Marco
    Sozzi, Giulio
    Dessole, Margherita
    Capobianco, Giampiero
    Dessole, Salvatore
    Madonia, Massimo
    Cherchi, Pier Luigi
    Paoletti, Anna Maria
    Scambia, Giovanni
    Chiantera, Vito
    SEMINARS IN CANCER BIOLOGY, 2021, 77 : 194 - 202
  • [34] Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study
    Coleman, Robert
    Oaknin, Ana
    Pignata, Sandro
    Denys, Hannelore
    Colombo, Nicoletta
    Van Gorp, Toon
    Konner, Jason
    Marin, Margarita Romeo
    Harter, Philipp
    Murphy, Conleth
    Esteves, Brooke
    Method, Michael
    Lorusso, Domenica
    Matulonis, Ursula
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S3 - S3
  • [35] A source of hope for platinum-resistant ovarian cancer?
    Blagden, Sarah P.
    Nicum, Shibani
    LANCET, 2021, 397 (10271): : 254 - 256
  • [36] Topotecan in platinum-resistant epithelial ovarian cancer
    Karabulut, B
    Sezgin, C
    Terek, MC
    Uslu, R
    Sanli, UA
    Akman, L
    Ozsaran, A
    Dikmen, Y
    Goker, E
    CHEMOTHERAPY, 2005, 51 (06) : 347 - 351
  • [37] ATR Inhibitors in Platinum-Resistant Ovarian Cancer
    Li, Siyu
    Wang, Tao
    Fei, Xichang
    Zhang, Mingjun
    CANCERS, 2022, 14 (23)
  • [38] Treatment Approaches for Platinum-Resistant Ovarian Cancer
    St Laurent, Jessica
    Liu, Joyce F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (02) : 127 - 133
  • [39] Update on Strategies for Platinum-Resistant Ovarian Cancer
    Pothuri, Bhavana
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (04) : 202 - 204
  • [40] Paclitaxel in platinum-resistant ovarian cancer patients
    Ezcurdia, L
    Jovtis, SL
    Mickiewicz, E
    Temperley, G
    Rondinon, M
    Blajman, C
    Coppola, FS
    Lewi, D
    Cazap, E
    Breier, S
    Fasce, H
    Fein, L
    Polera, J
    Triguboff, E
    Uranga, G
    Pasccon, G
    Luchina, AM
    Martinez, CA
    Politi, PM
    Rubio, G
    Alvarez, AM
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 53 - 56
12345